1. Lin, Yuxiang, Li, Yan, Chen, Xiaobin, Fu, Fangmeng, Wang, Chuan. 2024. YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway. In Biology direct, 19, 42. doi:10.1186/s13062-024-00481-2. https://pubmed.ncbi.nlm.nih.gov/38831379/
2. Oh, Jagyeong, Pradella, Davide, Shao, Changwei, Ghigna, Claudia, Shen, Haihong. 2021. Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells. In Cells, 10, . doi:10.3390/cells10040858. https://pubmed.ncbi.nlm.nih.gov/33918758/
3. Guo, Wei, Li, Guo-Jun, Xu, Hong-Bo, Chen, Xiao-Hong, Huang, Zhi-Gang. . In vitro biological characterization of DCUN1D5 in DNA damage response. In Asian Pacific journal of cancer prevention : APJCP, 13, 4157-62. doi:. https://pubmed.ncbi.nlm.nih.gov/23098533/
4. Bommeljé, Claire C, Weeda, Víola B, Huang, Guochang, Ramanathan, Suresh Y, Singh, Bhuvanesh. 2013. Oncogenic function of SCCRO5/DCUN1D5 requires its Neddylation E3 activity and nuclear localization. In Clinical cancer research : an official journal of the American Association for Cancer Research, 20, 372-81. doi:10.1158/1078-0432.CCR-13-1252. https://pubmed.ncbi.nlm.nih.gov/24192928/
5. Zhao, Song, Han, Xiaoli, Huang, Jingtao, Zhao, Baoshan, Liang, Zongying. 2025. DCUN1D5 is a prognostic biomarker and correlated immune infiltrates and glycolysis in lung adenocarcinoma. In Scientific reports, 15, 403. doi:10.1038/s41598-024-84539-1. https://pubmed.ncbi.nlm.nih.gov/39747313/
智鼠故事 
